INFRX
Infrx is an Australian start-up company specialising in development, marketing, implementation and support of the Facebook, Open Compute Project (OCP). OCP is a Facebook initiative to bring component level hardware to market. These components include Server, Storage, Networks, Racks and Hardware management software. The aim of OCP is to build the most efficient computing infrastructures at the lowest possible cost.
INFRX
Industry:
Enterprise Software Information Technology Software
Founded:
2013-12-04
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.infrx.com
Total Employee:
1+
Status:
Active
Contact:
+61 3 8060 9905
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache AdBlock Acceptable Ads Confluence Networks
Similar Organizations
Omikrosys
Web Services and Software Development
Seductive Turtle
Open Source Software Development
Current Employees Featured
Founder
Official Site Inspections
http://www.infrx.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Infrx"
InflammaNova Rx
STING inhibitor hit-to-lead IFNRx-H chemotype compounds were identified with previous funding from the NIH and the Michael J. Fox Foundation. Lead compound IFNRx-H001 significantly attenuates both STING activation and …See details»
InFlammaNova Rx, LLC | LinkedIn
IFNRx is now a member of BIOAlabama - looking forward to the Annual 2024 Conference and learning more about the bioscience ecosystem here in Alabama! Like Comment Share InFlammaNova Rx, LLCSee details»
Lisa Schwiebert - Co-Founder & CEO - InFlammaNova …
Co-Founder & CEO of InFlammaNova Rx, LLC · With over 25 years of experience in academic research and doctoral graduate education, I have …See details»
InFlammaNova Rx, LLC on LinkedIn: We are excited to announce …
We are excited to announce that IFNRx has recently received funding from The Michael J. Fox Foundation to further develop a novel therapeutic compound for the treatment of Parkinson's …See details»
InflaRx Company Profile | Management and Employees List
InflaRx Profile and History. InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary technology to discover and develop first-in-class or best-in …See details»
InflaRx - Org chart - The Org
Explore InflaRx's organizational chart. Discover current team members including executives, board members, and advisors.See details»
InflaRx N.V. (IFRX) Company Profile & Facts - Yahoo Finance
See the company profile for InflaRx N.V. (IFRX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
InflaRx - The Org
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific …See details»
InflaRx Management
2 days ago InflaRx's CEO is Niels Riedemann, appointed in Jan 2007, has a tenure of 18.25 years. directly owns 1.58% of the company’s shares, worth $1.13M.See details»
INFORX, INC. Company Profile | San Antonio, TX | Competitors ...
Find company research, competitor information, contact details & financial data for INFORX, INC. of San Antonio, TX. Get the latest business insights from Dun & Bradstreet.See details»
InFlammaNova Rx, LLC on LinkedIn: IFNRx, LLC is now a member …
IFNRx, LLC is now a member of Southern Research's Emerging Biotech StartUp Program! With this membership, we look forward to networking with other biotech…See details»
IFRX | InflaRx N.V. Company Profile & Executives - WSJ
Company profile for InflaRx N.V. including key executives, insider trading, ownership, revenue and average growth rates. View detailed IFRX description & address.See details»
InflaRx (IFRX) Company Profile & Description - Stock Analysis
Nov 8, 2017 Ticker Symbol: IFRX: Exchange: NASDAQ: Stock Type: Common Stock: Fiscal Year: January - December: Reporting Currency: EUR: CIK Code: 0001708688: CUSIP …See details»
InflaRX - Bain Capital Life Sciences
InflaRx (Nasdaq: IFRX) is a biotechnology company pioneering anti-inflammatory therapeutics by applying its proprietary anti-C5a and anti-C5aR technologies to discover, develop and …See details»
InflaRx Announces Closing of $30 Million Public Offering of
JENA, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics …See details»
InflaRx Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 InflaRx has 3 employees across 2 locations and €63 k in annual revenue in FY 2023. See insights on InflaRx including office locations, competitors, revenue, financials, …See details»
Lisa Schwiebert’s Post - LinkedIn
I am excited to start a new chapter as Co-Founder & CEO of InFlammaNova Rx, LLC! Together with colleagues and companies here in B’ham and around the globe, IFNRx is developing …See details»
InflaRx N.V. - AnnualReports.com
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific …See details»
InflaRx N.V. (IFRX): history, ownership, mission, how it works
Ever wondered how a biopharmaceutical company tackles critical inflammation by targeting a specific pathway like C5a? InflaRx N.V. stands at the forefront of this challenge, having …See details»
IFRX | InflaRx N.V. Profile - MarketWatch
InflaRx N.V. company facts, information and financial ratios from MarketWatch.See details»